Hinge Health (NYSE:HNGE) Director Sells $88,486.02 in Stock

Hinge Health Inc. (NYSE:HNGE) Director Kristina Leslie sold 2,187 shares of the company’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $40.46, for a total transaction of $88,486.02. Following the completion of the transaction, the director owned 32,813 shares of the company’s stock, valued at $1,327,613.98. This represents a 6.25% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Hinge Health Stock Performance

Shares of HNGE stock traded up $3.63 during mid-day trading on Wednesday, hitting $44.25. 5,591,654 shares of the stock were exchanged, compared to its average volume of 1,161,845. The firm’s fifty day moving average price is $50.45. Hinge Health Inc. has a 12-month low of $33.42 and a 12-month high of $62.18.

Hinge Health (NYSE:HNGE) last announced its earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.18. The firm had revenue of $154.21 million during the quarter, compared to analyst estimates of $142.44 million. Hinge Health’s revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its board has authorized a stock buyback plan on Wednesday, November 12th that permits the company to repurchase $250.00 million in shares. This repurchase authorization permits the company to purchase up to 7.2% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Analyst Upgrades and Downgrades

HNGE has been the topic of a number of research reports. Morgan Stanley raised their target price on shares of Hinge Health from $57.00 to $67.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 23rd. Wall Street Zen upgraded shares of Hinge Health from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Piper Sandler restated an “overweight” rating and issued a $71.00 price objective (up from $70.00) on shares of Hinge Health in a research note on Wednesday, November 5th. Baird R W raised shares of Hinge Health to a “hold” rating in a report on Friday, September 5th. Finally, Evercore ISI increased their target price on shares of Hinge Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $59.93.

Hedge Funds Weigh In On Hinge Health

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Sandler Capital Management increased its stake in Hinge Health by 1.4% in the 3rd quarter. Sandler Capital Management now owns 52,728 shares of the company’s stock valued at $2,588,000 after buying an additional 728 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Hinge Health in the 3rd quarter worth $37,000. Montag A & Associates Inc. purchased a new stake in shares of Hinge Health in the second quarter valued at about $41,000. Jones Financial Companies Lllp boosted its holdings in shares of Hinge Health by 348.0% in the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock valued at $54,000 after acquiring an additional 870 shares in the last quarter. Finally, SBI Securities Co. Ltd. acquired a new position in shares of Hinge Health during the second quarter worth about $48,000.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.